Weed Drinks That Get You Very, Very High Could Be Gone Soon

Hemp-derived THC beverages with very high doses—commonly 50mg and in some cases 100mg per 12‑oz can—have rapidly gained mainstream retail traction, with companies like Crescent Canna, Cantrip, Cycling Frog, St. Ides and CQ selling potent seltzers and sodas in grocery and convenience outlets; some firms also exploit serving-size interpretations to fit regulated limits. These products are driving strong consumer demand but are tailored to extreme intoxication, and the nascent category faces material regulatory risk because a ban on hemp would threaten their ability to be sold outside licensed dispensaries, creating potential disruption for producers, retailers and investors exposed to the segment.

Analysis

Hemp-derived THC beverages with very high potencies—commonly 50mg and up to 100mg per 12‑oz can—have achieved rapid mainstream retail traction, with Crescent Canna’s 50mg strawberry lemonade “selling out” according to CEO Joe Gerrity and brands such as Cantrip, Cycling Frog, St. Ides and CQ appearing on grocery and convenience shelves. These products differ from dispensary-only cannabis drinks because hemp derivation lets them be sold where beer and wine are available, and some producers are exploiting serving-size interpretations to fit within regulated limits while delivering extreme intoxication.

The article highlights a clear demand signal for high‑potency beverages but identifies a material regulatory vulnerability: a proposed or potential ban on hemp would threaten the legal basis for this retail channel and could force these products into licensed dispensaries or off shelves entirely. The combination of strong consumer uptake and concentrated regulatory risk creates asymmetric outcomes for revenues and inventory for producers and retailers.

For investors, the key tradeoff is near‑term growth from retail penetration versus regime risk from impending legislation or enforcement; monitoring legislative developments, retail delistings and compliance practices will determine whether this category scales or contracts rapidly, creating meaningful upside or downside for exposed companies.

Key Decisions for Investors

• Reduce or hedge exposure to pure‑play hemp‑derived THC beverage companies until regulatory clarity on hemp bans and serving‑size enforcement emerges
• Monitor state and federal legislative developments, retailer delistings, enforcement actions and inventory sell‑through as leading indicators of downside risk
• Prefer companies with diversified distribution (dispensary access or ability to reformulate to compliant THC levels) or clear compliance programs that can pivot if hemp sales are restricted